Crossref journal-article
Springer Science and Business Media LLC
Gene Therapy (297)
Bibliography

Furling, D., Doucet, G., Langlois, M.-A., Timchenko, L., Belanger, E., Cossette, L., & Puymirat, J. (2003). Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Therapy, 10(9), 795–802.

Authors 7
  1. D Furling (first)
  2. G Doucet (additional)
  3. M-A Langlois (additional)
  4. L Timchenko (additional)
  5. E Belanger (additional)
  6. L Cossette (additional)
  7. J Puymirat (additional)
References 36 Referenced 68
  1. Harper PS . Myotonic Dystrophy, 3rd edn. W.B. Saunder: London, UK, 1989, pp 293–322. / Myotonic Dystrophy by PS Harper (1989)
  2. Brooke JD et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992; 68: 799–808. (10.1016/0092-8674(92)90154-5) / Cell by JD Brooke (1992)
  3. Fu YH et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992; 255: 1256–1258. (10.1126/science.1546326) / Science by YH Fu (1992)
  4. Mahadevan M et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992; 255: 1253–1255. (10.1126/science.1546325) / Science by M Mahadevan (1992)
  5. Fu YH et al. Decreased expression of myotonin–protein kinase mRNA and protein in adult form of myotonic dystrophy. Science 1993; 260: 235–238. (10.1126/science.8469976) / Science by YH Fu (1993)
  6. Novelli G et al. Failure in detecting mRNA transcripts from the mutated allele in myotonic dystrophy muscle. Biochem Mol Biol Int 1993; 29: 291–297. / Biochem Mol Biol Int by G Novelli (1993)
  7. Hofmann-Radvanyi H et al. Myotonic dystrophy: absence of CTG enlarged transcript in congenital forms, and low expression of the normal allele. Hum Mol Genet 1993; 2: 1263–1267. (10.1093/hmg/2.8.1263) / Hum Mol Genet by H Hofmann-Radvanyi (1993)
  8. Boucher CA et al. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet 1995; 4: 1919–1925. (10.1093/hmg/4.10.1919) / Hum Mol Genet by CA Boucher (1995)
  9. Jansen G et al. Structural organization and development expression pattern of the DMR-N9 gene immediately upstream of the myotonic dystrophy locus. Hum Mol Genet 1995; 4: 843–852. (10.1093/hmg/4.5.843) / Hum Mol Genet by G Jansen (1995)
  10. Davis MB et al. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci 1997; 94: 7388–7393. (10.1073/pnas.94.14.7388) / Proc Natl Acad Sci by MB Davis (1997)
  11. Timchenko LT et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucl Acid Res 1996; 24: 4407–4414. (10.1093/nar/24.22.4407) / Nucl Acid Res by LT Timchenko (1996)
  12. Roberts R et al. Altered phosphorylation and intracellular distribution of a (CUG)(n) triplet repeat RNA binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci 1997; 94: 13221–13226. (10.1073/pnas.94.24.13221) / Proc Natl Acad Sci by R Roberts (1997)
  13. Philips AV, Timchenko LT, Cooper TA . Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998; 280: 737–741. (10.1126/science.280.5364.737) / Science by AV Philips (1998)
  14. Timchenko NA et al. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001; 276: 7820–7826. (10.1074/jbc.M005960200) / J Biol Chem by NA Timchenko (2001)
  15. Tiscornia G, Mahadevan MS . Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol Cell 2000; 5: 959–967. (10.1016/S1097-2765(00)80261-0) / Mol Cell by G Tiscornia (2000)
  16. Miller JW et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000; 19: 4439–4448. (10.1093/emboj/19.17.4439) / EMBO J by JW Miller (2000)
  17. Mankodi A et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000; 289: 1769–1773. (10.1126/science.289.5485.1769) / Science by A Mankodi (2000)
  18. Weiss B, Davidkova G, Zhou LW . Antisense RNA gene therapy for studying and moduling biological processes. Cell Mol Life Sci 1999; 55: 334–358. (10.1007/s000180050296) / Cell Mol Life Sci by B Weiss (1999)
  19. Weiss B . Antisense Oligonucleotides and Antisense RNA: Novel Pharmacological and Therapeutic Agents. CRC Press: Boca Raton, FL, 1997. / Antisense Oligonucleotides and Antisense RNA: Novel Pharmacological and Therapeutic Agents by B Weiss (1997)
  20. Birikh KR, Heaton PA, Eckstein F . The structure, function and application of the hammerhead ribozyme. Eur J Biochem 1997; 245: 1–16. (10.1111/j.1432-1033.1997.t01-3-00001.x) / Eur J Biochem by KR Birikh (1997)
  21. Caplen NJ et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001; 98: 9742–9747. (10.1073/pnas.171251798) / Proc Natl Acad Sci USA by NJ Caplen (2001)
  22. Bass BL, Weintraub H . An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 1988; 55: 1089–1098. (10.1016/0092-8674(88)90253-X) / Cell by BL Bass (1988)
  23. Scadden AD, Smith CW . Specific cleavage of hyper-edited dsRNAs. EMBO J 2001; 20: 4243–4252. (10.1093/emboj/20.15.4243) / EMBO J by AD Scadden (2001)
  24. Deschenes I et al. Increase in the proliferative capacity of human myoblasts by using the T antigen under the vimentin promoter control. Muscle & Nerve 1997; 20: 437–445. (10.1002/(SICI)1097-4598(199704)20:4<437::AID-MUS6>3.0.CO;2-B) / Muscle & Nerve by I Deschenes (1997)
  25. Furling D, Lemieux D, Taneja K, Puymirat J . Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul Disord 2001; 11: 728–735. (10.1016/S0960-8966(01)00226-7) / Neuromuscul Disord by D Furling (2001)
  26. Furling D, Marette A, Puymirat J . Insulin-like growth factor-I circumvents defective insulin action in human myotonic dystrophy skeletal muscle cells. Endocrinology 1999; 140: 4244–4250. (10.1210/endo.140.9.7057) / Endocrinology by D Furling (1999)
  27. Samuel CE . Mechanism of interferon action. Kinetics of interferon action in mouse L929 cells: phosphorylation of protein synthesis initiation factor elF-2 and ribosome-associated protein P1. Virology 1979; 93: 281–285. (10.1016/0042-6822(79)90300-3) / Virology by CE Samuel (1979)
  28. Samuel CE . Protein–nucleic acid interactions and cellular responses to interferon. Methods 1998; 15: 161–165. (10.1006/meth.1998.0620) / Methods by CE Samuel (1998)
  29. Zhou A, Hassel BA, Silverman RH . Expression cloning of 2-5A-dependent RNase: a uniquely regulated mediator of interferon action. Cell 1993; 72: 753–765. (10.1016/0092-8674(93)90403-D) / Cell by A Zhou (1993)
  30. Silverman RH . 2-5A dependent RNase L: a regulated endoribonuclease in the interferon system. In: D'Alessio G, Riodan JF (eds). Ribonucleases: Structure and Functions. Academic Press: New York, NY, 1997; pp 515–551. (10.1016/B978-012588945-2/50017-0) / Ribonucleases: Structure and Functions by RH Silverman (1997)
  31. Davis MB et al. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci 1997; 94: 7388–7393. (10.1073/pnas.94.14.7388) / Proc Natl Acad Sci by MB Davis (1997)
  32. Furling D et al. Defective satellite cells in congenital myotonic dystrophy. Hum Mol Genet 2001; 10: 2079–2087. (10.1093/hmg/10.19.2079) / Hum Mol Genet by D Furling (2001)
  33. Timchenko NA et al. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 2001; 2: 6927–6938. (10.1128/MCB.21.20.6927-6938.2001) / Mol Cell Biol by NA Timchenko (2001)
  34. Savkur RS, Philips AV, Cooper TA . Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001; 29: 40–47. (10.1038/ng704) / Nat Genet by RS Savkur (2001)
  35. Denizot F, Lang R . Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271–277. (10.1016/0022-1759(86)90368-6) / J Immunol Methods by F Denizot (1986)
  36. Sarabia V et al. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J Clin Invest 1992; 90: 1386–1395. (10.1172/JCI116005) / J Clin Invest by V Sarabia (1992)
Dates
Type When
Created 22 years, 4 months ago (April 17, 2003, 9:49 a.m.)
Deposited 3 years, 4 months ago (March 29, 2022, 10:06 p.m.)
Indexed 4 months ago (April 22, 2025, 3:12 a.m.)
Issued 22 years, 4 months ago (April 17, 2003)
Published 22 years, 4 months ago (April 17, 2003)
Published Online 22 years, 4 months ago (April 17, 2003)
Published Print 22 years, 3 months ago (May 1, 2003)
Funders 0

None

@article{Furling_2003, title={Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions}, volume={10}, ISSN={1476-5462}, url={http://dx.doi.org/10.1038/sj.gt.3301955}, DOI={10.1038/sj.gt.3301955}, number={9}, journal={Gene Therapy}, publisher={Springer Science and Business Media LLC}, author={Furling, D and Doucet, G and Langlois, M-A and Timchenko, L and Belanger, E and Cossette, L and Puymirat, J}, year={2003}, month=apr, pages={795–802} }